drugset / Trial / NCT01779466
Daytime Impact Sleep Study
RandomizedParallel-groupTriple-blindTreatment
Summary
This trial will investigate the relationship of sleep, daytime performance and nocturia in patients treated with Desmopressin or placebo. Male and Female patients will be administered Desmopressin or Placebo every day for 3 months.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | — | Oral |